Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1981 1
1982 1
1983 2
1984 3
1985 2
1986 3
1987 2
1988 6
1989 1
1990 5
1991 2
1992 4
1993 3
1994 3
1995 2
1996 2
1997 17
1998 1
1999 1
2000 5
2001 3
2002 12
2003 6
2004 11
2005 3
2006 4
2007 2
2008 4
2009 7
2010 2
2011 6
2012 1
2013 5
2014 2
2015 5
2016 4
2017 5
2018 4
2019 4
2020 4
2021 4
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Malignant hyperthermia, susceptibility to, 4"
Page 1
Malignant hyperthermia: a review.
Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Rosenberg H, et al. Orphanet J Rare Dis. 2015 Aug 4;10:93. doi: 10.1186/s13023-015-0310-1. Orphanet J Rare Dis. 2015. PMID: 26238698 Free PMC article. Review.
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane, isoflurane and the depolarizing muscle relaxant succinylcholine, a …
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to pot …
Genetic epidemiology of malignant hyperthermia in the UK.
Miller DM, Daly C, Aboelsaod EM, Gardner L, Hobson SJ, Riasat K, Shepherd S, Robinson RL, Bilmen JG, Gupta PK, Shaw MA, Hopkins PM. Miller DM, et al. Br J Anaesth. 2018 Oct;121(4):944-952. doi: 10.1016/j.bja.2018.06.028. Epub 2018 Aug 17. Br J Anaesth. 2018. PMID: 30236257 Free PMC article.
BACKGROUND: Gaps in our understanding of genetic susceptibility to malignant hyperthermia (MH) limit the application and interpretation of genetic diagnosis of the condition. ...There was genotype-phenotype discordance in 86 of 328 families suitable for segre …
BACKGROUND: Gaps in our understanding of genetic susceptibility to malignant hyperthermia (MH) limit the application an …
Malignant hyperthermia.
Ali SZ, Taguchi A, Rosenberg H. Ali SZ, et al. Best Pract Res Clin Anaesthesiol. 2003 Dec;17(4):519-33. doi: 10.1016/j.bpa.2003.09.012. Best Pract Res Clin Anaesthesiol. 2003. PMID: 14661655 Review.
Malignant hyperthermia (MH) is an uncommon, life-threatening, acute pharmacogenetic disorder of the skeletal muscle cell. ...The ryanodine receptor, the calcium-release channel of the sarcoplasmic reticulum, is the primary locus for malignant hypothermia s …
Malignant hyperthermia (MH) is an uncommon, life-threatening, acute pharmacogenetic disorder of the skeletal muscle cell. ...T …
Malignant hyperthermia.
Halliday NJ. Halliday NJ. J Craniofac Surg. 2003 Sep;14(5):800-2. doi: 10.1097/00001665-200309000-00039. J Craniofac Surg. 2003. PMID: 14501352
Malignant Hyperthermia (MH) has been a recognized complication of general anesthesia after the first case reports in the 1940's. ...The caffeine/halothane testing of muscle biopsies is currently the most definitive test for malignant hyperthermia su …
Malignant Hyperthermia (MH) has been a recognized complication of general anesthesia after the first case reports in the 1940' …
Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility.
van den Bersselaar LR, van Alfen N, Kruijt N, Kamsteeg EJ, Fernandez-Garcia MA, Treves S, Riazi S, Yang CY, Malagon I, van Eijk LT, van Engelen BGM, Scheffer GJ, Jungbluth H, Snoeck MMJ, Voermans NC. van den Bersselaar LR, et al. J Neuromuscul Dis. 2023;10(4):541-554. doi: 10.3233/JND-230018. J Neuromuscul Dis. 2023. PMID: 37154182 Free PMC article.
Muscle imaging abnormalities have been demonstrated in isolated cases of patients with a history of RYR1-related malignant hyperthermia (MH) susceptibility. OBJECTIVE: To provide insights into the type and prevalence of muscle ultrasound abnormalities and mus …
Muscle imaging abnormalities have been demonstrated in isolated cases of patients with a history of RYR1-related malignant hyperth …
Management of patients susceptible to malignant hyperthermia: A surgeon's perspective.
Carlson KJ, Sun SA, Swan C, Koenig M, Derkay CS. Carlson KJ, et al. Int J Pediatr Otorhinolaryngol. 2022 Aug;159:111187. doi: 10.1016/j.ijporl.2022.111187. Epub 2022 May 30. Int J Pediatr Otorhinolaryngol. 2022. PMID: 35660936
OBJECTIVES: Malignant hyperthermia (MH) susceptibility caries broad implications for the care of pediatric surgical patients. ...No study subjects received muscle biopsy and contracture testing and only 5 (4%) underwent genetic testing for genomic vari …
OBJECTIVES: Malignant hyperthermia (MH) susceptibility caries broad implications for the care of pediatric surgical pat …
Malignant hyperthermia, coexisting disorders, and enzymopathies: risks and management options.
Benca J, Hogan K. Benca J, et al. Anesth Analg. 2009 Oct;109(4):1049-53. doi: 10.1213/ane.0b013e3181adca28. Anesth Analg. 2009. PMID: 19762731 Review.
Clinical episodes and abnormal laboratory tests compatible with a diagnosis of malignant hyperthermia have been observed in patients with a diversity of syndromes, enzymopathies, and coexisting disorders thereby raising the likelihood of causal associations and heig …
Clinical episodes and abnormal laboratory tests compatible with a diagnosis of malignant hyperthermia have been observed in pa …
Susceptibility of epithelial tumour cell lines to hyperthermia.
Li ZX, Wang HX, Yang Y, Qi RQ, Li YL, Yu AJ, Gao XH. Li ZX, et al. Eur J Dermatol. 2018 Oct 1;28(5):606-612. doi: 10.1684/ejd.2018.3417. Eur J Dermatol. 2018. PMID: 30530432
BACKGROUND: Human skin or mucosa exposes cells to both an internal and exogeneous thermal environment and the cells survive within a certain range of temperature. Exogeneous hyperthermia has been applied for the treatment of various types of cancers, fungal disease, …
BACKGROUND: Human skin or mucosa exposes cells to both an internal and exogeneous thermal environment and the cells survive within a certain …
Malignant hyperthermia.
Dunn D. Dunn D. AORN J. 1997 Apr;65(4):728, 731, passim; quiz 755-8, 760-2. doi: 10.1016/s0001-2092(06)62996-7. AORN J. 1997. PMID: 9093738 Review.
Malignant hyperthermia (MH) is a medical emergency that all perioperative nurses should be prepared to handle. Patients with the inherited MH trait have a rare skeletal muscle disease that causes them to develop life-threatening hyperthermia (ie, body …
Malignant hyperthermia (MH) is a medical emergency that all perioperative nurses should be prepared to handle. Patients with t …
172 results